Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Transportation and warehousing tags : Positive save search
Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
Published: 2023-10-25 (Crawled : 14:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -0.31%
H: 0.0%
C: -23.0%
sbi-100 glaucoma agonist positive bioscience treatment trial results
Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-07-13 (Crawled : 16:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -6.1%
H: 6.5%
C: 4.5%
sbi-100 review positive bioscience study
Skye Bioscience Receives Positive Safety Review in First Multiple-Administration Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -0.67%
H: 16.11%
C: 7.38%
sbi-100 review positive bioscience study
Skye Bioscience Receives Positive Safety Review of Third Cohort in Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-04-04 (Crawled : 15:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -1.33%
H: 17.57%
C: 14.86%
sbi-100 review positive bioscience study
Skye Bioscience Receives Positive Safety Review of SBI-100 Ophthalmic Emulsion After Second Cohort of Phase 1 Study
Published: 2023-02-23 (Crawled : 16:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: 1.01%
H: 25.67%
C: 7.67%
sbi-100 review positive bioscience study ophthalmic emulsion phase 1
Skye Bioscience Achieves Positive Safety Review of SBI-100 Ophthalmic Emulsion After Phase 1 First Cohort
Published: 2023-01-31 (Crawled : 15:20) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -5.17%
H: 36.36%
C: 21.82%
sbi-100 review positive bioscience ophthalmic emulsion phase 1
Skye Bioscience Reports Positive Results for SBI-100 in GLP Toxicology Study
Published: 2022-02-16 (Crawled : 14:00) - biospace.com/
SKYE | $12.845 -8.45% -9.23% 110K
|
Transportation and Warehousing
|
| O: -2.11%
H: 33.85%
C: 28.62%
sbi-100 positive results 100 report positive bioscience results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.